Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Tag Archives: Ovarian Cancer Early Detection Study

Symptoms Of Ovarian Cancer Remain Relatively Stabile Over Time As Reported By High Risk Women

Posted on May 17, 2009 by Paul Cacciatore

Researchers from the Fred Hutchinson Cancer Research Center reported recently that symptoms of ovarian cancer tend to be relatively stable over time for women who are at increased risk of ovarian cancer based upon family history of cancer or BRCA 1/2 gene mutation.

Continue reading →

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Reddit (Opens in new window) Reddit
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email
Like Loading...
Posted in Medical Study Results, Symptoms | Tagged American Cancer Society, Barbara A. Goff M.D., BRCA gene mutations, BRCA1, BRCA2, early warning signs & symptoms, Fred Hutchinson Cancer Research Institute, Gynecologic Cancer Foundation, ovarian cancer, Ovarian Cancer Early Detection Study, Society of Gynecologic Oncologists, Symptoms Index, Univ. of Washington | Leave a comment
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

RSS Google Ovarian Cancer News

  • Repurposed drug may extend survival in aggressive ovarian cancer, trial shows - The Guardian
  • This Is How Ovarian Cancer Spreads Before Doctors Can Detect - SciTechDaily
  • Radon and Ovarian Cancer; FDA Rejects Drug Again; Missed Chances for Genomic Testing - MedPage Today
  • Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer - Yahoo Finance
  • Verastem Oncology’s combo shows two-year durability in ovarian cancer - Clinical Trials Arena
  • Pill for Cushing's syndrome could benefit patients with treatment resistant ovarian cancer, study suggests - Sky News
  • Landmark Study Led by Roswell Park Expert Shows Survival Benefit of Immunotherapy in Resistant Ovarian Cancer - Roswell Park Comprehensive Cancer Center
  • Hundreds attend Geaux Teal Ovarian Cancer Awareness Walk - WBRZ
  • Vanja knew nothing about the lethal disease growing inside her. Countless Aussie women are in the same boat - Nine Honey
  • Half of KRAS-mutant ovarian cancer patients stayed on combo over a year - Stock Titan

Top Posts

  • About
    About
  • An Attitude of Gratitude On Thanksgiving Day
    An Attitude of Gratitude On Thanksgiving Day
  • Ovarian Cancer Survivor Seeks "Compassionate Use" Drug Exemption From BioMarin to Save Her Life
    Ovarian Cancer Survivor Seeks "Compassionate Use" Drug Exemption From BioMarin to Save Her Life
  • SNS-595 Shows Promise For Platinum-Resistant Ovarian Cancer Patients
    SNS-595 Shows Promise For Platinum-Resistant Ovarian Cancer Patients
  • UCLA Researchers Significantly Inhibit Growth of Ovarian Cancer Cell Lines With FDA-Approved Leukemia Drug Dasatinib (Sprycel®)
    UCLA Researchers Significantly Inhibit Growth of Ovarian Cancer Cell Lines With FDA-Approved Leukemia Drug Dasatinib (Sprycel®)
  • U.S. Food & Drug Administration Acts to Bolster Supply of Critically Needed Cancer Drugs Including Doxil
    U.S. Food & Drug Administration Acts to Bolster Supply of Critically Needed Cancer Drugs Including Doxil
  • WIH Researchers Examine Role of Hormone HE4 in Patient Responses to Ovarian Cancer Treatment
    WIH Researchers Examine Role of Hormone HE4 in Patient Responses to Ovarian Cancer Treatment
  • Surgery
    Surgery
  • Contact
    Contact
  • European Researchers Find Estrogen Receptor Gene Amplification Occurs Rarely in Ovarian Cancer
    European Researchers Find Estrogen Receptor Gene Amplification Occurs Rarely in Ovarian Cancer

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 507,398 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 342 other subscribers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
  • Intensification Treatment of Ovarian Cancer by PIPAC
  • Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery
  • Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
  • Ovarian Cancer Screening and AI
  • A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates
  • Phase 1 Study of PF-08046033 in Advanced Solid Tumors
  • A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
  • Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
  • A Study of Ivonescimab in People With Leiomyosarcoma
  • Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
  • First-In-Human Study of KHN922 for Injection
  • GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
  • TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
  • JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

RSS Medical Studies

  • The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications
  • Overexpression of COL10A1 in extracellular matrix predicts poor outcome and promotes ovarian cancer progression
  • Correspondence on "Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer" by Kim et al
  • Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women
  • Prediction of chemoresistance in ovarian cancer based on deep learning with pathological images
  • Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy
  • Presence and prevalence of single nucleotide sequence polymorphisms in TP53 and BRCA2 genes as of cervical and ovarian cancers in women using hormonal contraceptives in Abuja, Nigeria
  • Surgical education video: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer
  • MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer
  • PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells

Recent Comments

Prometey Bank's avatarPrometey Bank on World Ovarian Cancer Day: Toge…
mikaljhohnashly's avatarmikaljhohnashly on World Ovarian Cancer Day: Toge…
Jan C. Calthrop's avatarJan C. Calthrop on Lab-On-A-Chip: Veridex & M…
Paul Cacciatore's avatarPaul Cacciatore on About
Building a Team for… on About
Kathleen's avatarKathleen on About
Paul Cacciatore's avatarPaul Cacciatore on About
Liz's avatarLiz on About
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere's avatarJudith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini's avatarFranca Pichini on Dana Farber Webchat: The Lates…
painspeaks's avatarpainspeaks on SU2C Announces the Formation o…
marcy westerling's avatarmarcy westerling on SU2C Announces the Formation o…
anne's avataranne on Dana-Farber Oncologists Differ…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
  • Subscribe Subscribed
    • Libby's H*O*P*E*
    • Join 217 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Libby's H*O*P*E*
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
%d